HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents.

Abstract
Leptin is a hormone that reduces excitability in some hypothalamic neurons via leptin receptor activation of the JAK2 and PI3K intracellular signaling pathways. We hypothesized that leptin receptor activation in other neuronal subtypes would have anticonvulsant activity and that intranasal leptin delivery would be an effective route of administration. We tested leptin's anticonvulsant action in 2 rodent seizure models by directly injecting it into the cortex or by administering it intranasally. Focal seizures in rats were induced by neocortical injections of 4-aminopyridine, an inhibitor of voltage-gated K+ channels. These seizures were briefer and less frequent upon coinjection of 4-aminopyridine and leptin. In mice, intranasal administration of leptin produced elevated brain and serum leptin levels and delayed the onset of chemical convulsant pentylenetetrazole-induced generalized convulsive seizures. Leptin also reduced neuronal spiking in an in vitro seizure model. Leptin inhibited alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) receptor-mediated synaptic transmission in mouse hippocampal slices but failed to inhibit synaptic responses in slices from leptin receptor-deficient db/db mice. JAK2 and PI3K antagonists prevented leptin inhibition of AMPAergic synaptic transmission. We conclude that leptin receptor activation and JAK2/PI3K signaling may be novel targets for anticonvulsant treatments. Intranasal leptin administration may have potential as an acute abortive treatment for convulsive seizures in emergency situations.
AuthorsLin Xu, Nicholas Rensing, Xiao-Feng Yang, Hai Xia Zhang, Liu Lin Thio, Steven M Rothman, Aryan E Weisenfeld, Michael Wong, Kelvin A Yamada
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 118 Issue 1 Pg. 272-80 (Jan 2008) ISSN: 0021-9738 [Print] United States
PMID18097472 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Convulsants
  • Leptin
  • Phosphoinositide-3 Kinase Inhibitors
  • Potassium Channel Blockers
  • Potassium Channels, Voltage-Gated
  • Receptors, AMPA
  • Receptors, Leptin
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • 4-Aminopyridine
  • Jak2 protein, mouse
  • Jak2 protein, rat
  • Janus Kinase 2
  • Pentylenetetrazole
Topics
  • 4-Aminopyridine (toxicity)
  • Administration, Intranasal
  • Animals
  • Convulsants (toxicity)
  • Hypothalamus (metabolism, pathology)
  • Janus Kinase 2 (antagonists & inhibitors, genetics, metabolism)
  • Leptin (pharmacokinetics, pharmacology, therapeutic use)
  • Male
  • Mice
  • Mice, Knockout
  • Neurons (metabolism, pathology)
  • Pentylenetetrazole (toxicity)
  • Phosphatidylinositol 3-Kinases (genetics, metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Potassium Channel Blockers (toxicity)
  • Potassium Channels, Voltage-Gated (antagonists & inhibitors, genetics, metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA (genetics, metabolism)
  • Receptors, Leptin (agonists, genetics, metabolism)
  • Seizures (chemically induced, drug therapy, genetics, metabolism, pathology)
  • Synaptic Transmission (drug effects, genetics)
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: